Members Members Residents Residents Corner
Join Today Renew Your Membership Make A Donation
2001 Abstract: 1789 Protective Effect of a Selective Endothelin A Receptor Antagonist (BSF 208075) on Graft Pancreatitis in a Pig Transplant Model

2001 Digestive Disease Week

# 1789 Protective Effect of a Selective Endothelin A Receptor Antagonist (BSF 208075) on Graft Pancreatitis in a Pig Transplant Model
Helmut Witzigmann, Stefan Ludwig, Evelin Escher, Gabor Gaebel, Beate Armann, D. Teupser, Andrea Tannapfel, Dirk Uhlmann, Johann Hauss, Leipzig, Germany

Objective: To evaluate the effect of a new Endothelin A receptor antagonist (ET-RA) on pancreatic microcirculation in a pig transplant model. Background: Impaired microcirculation is a major determinant of graft pancreatitis post transplant in humans. In animal models Endothelin 1 has been shown to reduce local blood flow in the pancreas and to aggravate pancreatitis.

Methods: Heterotopic pancreas transplantation was performed in Göttinger minipigs (n = 16 donors, n=16 recipients, female 20-25 kg). The grafts were stored for 6 hours in University of Wisconsin solution at 4C. Cyclosporine A and Prednisolon were administered for immunosuppression. The animals were randomized to a control (n = 8) and treatment group (n = 8) that received 10 mg/kg of the selective endothelin A receptor antagonist (BSF 208075) i.v. during reperfusion and after 6 h. Target parameter measured before and after reperfusion included quantification of the morphological damage by a score, tissue oxygenation, laser doppler flowmetry, serum amylase, serum lipase, and trypsinogen-activation peptide (TAP).

Results: A rapid onset of morphological alterations immediately after reperfusion was noted. The tissue damage score was significant lower in the treatment group (p<0,05). 60 min after reperfusion pO2 values were significant better in the treatment group (83.1% ± 9.7% of basal values vs. control group: 45.4% ± 12.1%; p< 0.05). Laser doppler-flowmetry showed also a significant improvement of erythrocyte flux in the treatment group (78.4% ± 8.2% of basal values vs. control: 47.1% ± 13.3%; p< 0.05). 60 min after reperfusion serum amylase (treatment 22.6 ± 5.3 µmol/l vs control: 81,0 ± 20,1 µmol/l) but not lipase and 6 hours after reperfusion serum lipase (treatment: 4.7 ± 1.0 µmol/l vs control: 9.8 ± 1.2 µmol/l), but not amylase values were significant lower in therapy group (p<0.05). TAP values measured at its maximum 45 min after reperfusion revealed no significant differences.

Conclusion: There is a marked impairment of pancreatic microcirculation after reperfusion. A selective endothelin A receptor antagonist counteracts this impairment and has a protective effect on ischemia/reperfusion injury after pancreas transplantation.

Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email AAPS Email AAPS
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Annual Meeting
Make a Pledge
Event Calendar